Advertisement

Topics

Global Metabolic Disorders Therapeutics Market 20162020 Prices from USD $2500

18:12 EST 1 Dec 2016 | BioPortfolio Reports

About Metabolic Disorders

Metabolic disorders occur as a result of disruption of chemical processes and conversions occurring in the cells and fluids of the body. This is mainly because of defects in the enzyme; all process in the body are controlled by enzymes. Any disruption in the pathways involved in the development and metabolism of carbohydrates, proteins, fats, and nucleic acids, results in the development of metabolic disorders.

Technavio's analysts forecast the global metabolic disorders therapeutics market to grow at a CAGR of 4.62% during the period 20162020.

Covered in this report
The report covers the present scenario and the growth prospects of the global metabolic disorders therapeutics market for 20162020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and offlabel drugs used for the treatment of various metabolic disorders including diabetes, obesity, lysosomal storage diseases, and hypercholesterolemia.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Metabolic Disorders Therapeutics Market 20162020, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Novo Nordisk
Sanofi
Merck
AstraZeneca
Eli Lilly

Other prominent vendors
AbbVie
Actelion Pharmaceuticals
Adocia
Aegerion Pharmaceuticals
Akros Pharma
Alnylam Pharmaceuticals
Amarin
nAmgen
Amicus Therapeutics
Arbutus Biopharma
Arena Pharmaceuticals
Astellas Pharma
Atheronova
Aurobindo Pharma
Baxalta
Belrose Pharma
BHV Pharma
Biocon
Biodel
BioMarin
Bionaturis
Biosidus
Biospherics
Boehringer Ingelheim
BristolMyers Squibb
Catabasis Pharmaceuticals
Cerenis Therapeutics
Chipscreen Biosciences
Cipla
CJ HealthCare
CKD Bio
Concord Biotech
ConjuChem
CureDm
CymaBay Therapeutics
Daewoong
Daiichi Sankyo
Dance Biopharm
DiaMedica
Diamyd Therapeutics
Diasome Pharmaceuticals
DiaVacs
DongA ST
Eisai
Elcelyx Therapeutics
Esperion Therapeutics
Exsulin
F. HoffmannLa Roche
Gan Lee Pharmaceuticals
Generex Biotechnology
Genfit
GlaxoSmithKline
HanAll BioPharma
Hanmi Pharmaceutical Company
Hua Medicine
Iltoo Pharma
Intarcia Therapeutics
InteKrin Therapeutics
Intrexon
Ionis Pharmaceuticals
Islet Sciences
ISU Abxis
Janssen Pharmaceuticals
Japan Tobacco
JCR Pharmaceuticals
JW Pharmaceuticals
Kadmon Pharmaceuticals
Kamada
KinDex Pharmaceuticals
Kissei
Kotobuki
Kowa Company
Laboratoires SMB
Lexicon Pharmaceuticals
Ligand Pharmaceuticals
Living Cell Technologies
Livzon
LIXTE Biotechnology
Lupin
MacroGenics
Madrigal Pharmaceuticals
MannKind
MedImmune
Melior Pharmaceuticals
Merrion Pharmaceuticals
Merz Pharmaceuticals
Metabolic Solutions Development Company
Mitsubishi Tanabe Pharma
Mylan
Neothetics
Neuraltus Pharmaceuticals
NGM Biopharmaceuticals
NGM Biopharmaceuticals
Norgine BV
Novartis
NuSirt Biopharma
Oramed
Orexigen Therapeutics
Osiris Therapeutics
Peptron
Perle Biosciences
Pfizer
PhaseBio Pharmaceuticals
Poxel
Protalix Biotherapeutics
Raptor
Recordati
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
REGiMMUNE
Rhythm Pharmaceuticals
Saniona
Santaris Pharma
Santaris Pharma
Serometrix
Shionogi
Shire
SigmaTau
Sirona Biochem
Strongbridge Biopharma
SUN Pharma
Takeda
Teva
Thera technologies
Theracos
Toleranzia
Tolerion
Torrent Pharmaceuticals
Transition Therapeutics
UCB
Utrecht Holdings
VeroScience
Vivus
vTv Therapeutics
XBiotech
Xeris Pharmaceuticals
XOMA
Zafgen
Zydus Cadila

Market driver
Increase in academiaindustry collaborations for drug development
For a full, detailed list, view our report

Market challenge
Low compliance and adherence rates
For a full, detailed list, view our report

Market trend
Increase in academiaindustry collaborations for drug development
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Original Article: Global Metabolic Disorders Therapeutics Market 20162020 Prices from USD $2500

NEXT ARTICLE

More From BioPortfolio on "Global Metabolic Disorders Therapeutics Market 20162020 Prices from USD $2500"

Quick Search
Advertisement
 

Relevant Topics

Enzymes
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...